Treatment approaches for managing patients with hematological malignancies in the time of COVID-19 pandemic

Creative Commons License

CENGİZ SEVAL G., TOPÇUOĞLU P., DEMİRER T.

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.6, ss.2799-2809, 2021 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 51 Sayı: 6
  • Basım Tarihi: 2021
  • Doi Numarası: 10.3906/sag-2101-276
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.2799-2809
  • Anahtar Kelimeler: COVID-19, SARS-CoV-2, hematological malignancies, HIGH-DOSE CHEMOTHERAPY, MULTIPLE-MYELOMA, BREAST-CANCER, LEUKEMIA, MARROW, TRANSPLANTATION, GUIDELINES, MANAGEMENT, RISK
  • Ankara Üniversitesi Adresli: Evet

Özet

Background/aim: The COVID-19 pandemic is a unique challenge to the care of patients with hematological malignancies. We aim to provide supportive guidance to clinicians making individual patients decisions during the COVID-19 pandemic, in particular during periods that access to healthcare resources may be limited.